Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp. 1721-1730
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.04.095

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagerty, R. G.
Right arrow Articles by Tattersall, M. H.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagerty, R. G.
Right arrow Articles by Tattersall, M. H.N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting

Rebecca G. Hagerty, Phyllis N. Butow, Peter A. Ellis, Elizabeth A. Lobb, Susan Pendlebury, Natasha Leighl, David Goldstein, Sing Kai Lo, Martin H.N. Tattersall

From the Medical Psychology Research Unit and the Department of Cancer Medicine, University of Sydney, Sydney; and Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Address reprint requests to Phyllis Butow, PhD, Medical Psychology Research Unit, Blackburn Building, D06, University of Sydney, Sydney, NSW 2006, Australia; e-mail: phyllisb{at}med.usyd.edu.au

PURPOSE: To identify preferences for and predictors of prognostic information among patients with incurable metastatic cancer.

PATIENTS AND METHODS: One hundred twenty-six metastatic cancer patients seeing 30 oncologists at 12 outpatient clinics in New South Wales, Australia, participated in the study. Patients were diagnosed with incurable metastatic disease within 6 weeks to 6 months of recruitment. Patients completed a survey eliciting their preferences for prognostic information, including type, quantity, mode, and timing of presentation; anxiety and depression levels; and information and involvement preferences.

RESULTS: More than 95% of patients wanted information about side effects, symptoms, and treatment options. The majority wanted to know longest survival time with treatment (85%), 5-year survival rates (80%), and average survival (81%). Words and numbers were preferred over pie charts or graphs. Fifty-nine percent (59%) wanted to discuss expected survival when first diagnosed with metastatic disease. Thirty-eight percent and 44% wanted to negotiate when expected survival and dying, respectively, were discussed. Patients with higher depression scores were more likely to want to know shortest time to live without treatment (P = .047) and average survival (P = .049). Lower depression levels were significantly associated with never wanting to discuss expected survival (P = .03). Patients with an expected survival of years were more likely to want to discuss life expectancy when first diagnosed with metastases (P = .02).

CONCLUSION: Most metastatic cancer patients want detailed prognostic information but prefer to negotiate the extent, format, and timing of the information they receive from their oncologists.

Supported by the New South Wales Cancer Council.

Presented at the 29th Annual Scientific Meeting of the Clinical Oncological Society of Australia, Sydney, 2002.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CA Cancer J ClinHome page
E. Finlay and D. Casarett
Making Difficult Discussions Easier: Using Prognosis to Facilitate Transitions to Hospice
CA Cancer J Clin, July 1, 2009; 59(4): 250 - 263.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
E Michiels, R Deschepper, J Bilsen, F Mortier, and L Deliens
Information disclosure to terminally ill patients and their relatives: self-reported practice of Belgian clinical specialists and general practitioners
Palliative Medicine, June 1, 2009; 23(4): 345 - 353.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
H. A. Huskamp, N. L. Keating, J. L. Malin, A. M. Zaslavsky, J. C. Weeks, C. C. Earle, J. M. Teno, B. A. Virnig, K. L. Kahn, Y. He, et al.
Discussions With Physicians About Hospice Among Patients With Metastatic Lung Cancer
Arch Intern Med, May 25, 2009; 169(10): 954 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Med. EthicsHome page
N B A T Janssen, F J Oort, P Fockens, D L Willems, H C J M de Haes, and E M A Smets
Under what conditions do patients want to be informed about their risk of a complication? A vignette study
J. Med. Ethics, May 1, 2009; 35(5): 276 - 282.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.-J. Au, C. S. Karapetis, C. J. O'Callaghan, D. Tu, M. J. Moore, J. R. Zalcberg, H. Kennecke, J. D. Shapiro, S. Koski, N. Pavlakis, et al.
Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and KRAS-Specific Results of the NCIC CTG and AGITG CO.17 Trial
J. Clin. Oncol., April 10, 2009; 27(11): 1822 - 1828.
[Abstract] [Full Text] [PDF]


Home page
Journal of Research in NursingHome page
R. Maguire, J. Cowie, C. Leadbetter, K. McCall, K. Swingler, L. McCann, and N. Kearney
The development of a side effect risk assessment tool (ASyMS(C)-SERAT) for use in patients with breast cancer undergoing adjuvant chemotherapy
Journal of Research in Nursing, January 1, 2009; 14(1): 27 - 40.
[Abstract] [PDF]


Home page
Palliat MedHome page
S Innes and S Payne
Advanced cancer patients' prognostic information preferences: a review
Palliative Medicine, January 1, 2009; 23(1): 29 - 39.
[Abstract] [PDF]


Home page
JCOHome page
C. K. Daugherty and F. J. Hlubocky
What Are Terminally Ill Cancer Patients Told About Their Expected Deaths? A Study of Cancer Physicians' Self-Reports of Prognosis Disclosure
J. Clin. Oncol., December 20, 2008; 26(36): 5988 - 5993.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. A. Wright, B. Zhang, A. Ray, J. W. Mack, E. Trice, T. Balboni, S. L. Mitchell, V. A. Jackson, S. D. Block, P. K. Maciejewski, et al.
Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
JAMA, October 8, 2008; 300(14): 1665 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Med. EthicsHome page
A B Astrow, J R Sood, M T Nolan, P B Terry, L Clawson, J Kub, M Hughes, and D P Sulmasy
Decision-making in patients with advanced cancer compared with amyotrophic lateral sclerosis
J. Med. Ethics, September 1, 2008; 34(9): 664 - 668.
[Abstract] [Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
F. Twomey, N. O'Leary, and T. O'Brien
Prediction of Patient Survival by Healthcare Professionals in a Specialist Palliative Care Inpatient Unit: A Prospective Study
American Journal of Hospice and Palliative Medicine, May 1, 2008; 25(2): 139 - 145.
[Abstract] [PDF]


Home page
JCOHome page
S. Gabrijel, L. Grize, E. Helfenstein, M. Brutsche, P. Grossman, M. Tamm, and A. Kiss
Receiving the Diagnosis of Lung Cancer: Patient Recall of Information and Satisfaction With Physician Communication
J. Clin. Oncol., January 10, 2008; 26(2): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
A. L. Back, R. M. Arnold, and J. A. Tulsky
Discussing Prognosis
ASCO Educational Book, January 1, 2008; 2008(1): 135 - 138.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
F. Efficace, A. Novik, M. Vignetti, F. Mandelli, and C. S. Cleeland
Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?
Haematologica, December 1, 2007; 92(12): 1596 - 1598.
[Full Text] [PDF]


Home page
Ann OncolHome page
M Sanjo, M Miyashita, T Morita, K Hirai, M Kawa, T Akechi, and Y Uchitomi
Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan
Ann. Onc., September 1, 2007; 18(9): 1539 - 1547.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Buckman and W. Baile
Truth Telling: Yes, but How?
J. Clin. Oncol., July 20, 2007; 25(21): 3181 - 3181.
[Full Text] [PDF]


Home page
JCOHome page
J. W. Mack, E. F. Cook, J. Wolfe, H. E. Grier, P. D. Cleary, and J. C. Weeks
Understanding of Prognosis Among Parents of Children With Cancer: Parental Optimism and the Parent-Physician Interaction
J. Clin. Oncol., April 10, 2007; 25(11): 1357 - 1362.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F Efficace, D Osoba, C Gotay, M Sprangers, C Coens, and A Bottomley
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making
Ann. Onc., April 1, 2007; 18(4): 775 - 781.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G Oskay-Ozcelik, W Lehmacher, D Konsgen, H Christ, M Kaufmann, W Lichtenegger, M Bamberg, D Wallwiener, F Overkamp, K Diedrich, et al.
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients
Ann. Onc., March 1, 2007; 18(3): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. W. Mack, J. Wolfe, H. E. Grier, P. D. Cleary, and J. C. Weeks
Communication About Prognosis Between Parents and Physicians of Children With Cancer: Parent Preferences and the Impact of Prognostic Information
J. Clin. Oncol., November 20, 2006; 24(33): 5265 - 5270.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
P. Schofield, M. Carey, A. Love, C. Nehill, and S. Wein
'Would you like to talk about your future treatment options?' discussing the transition from curative cancer treatment to palliative care
Palliative Medicine, June 1, 2006; 20(4): 397 - 406.
[Abstract] [PDF]


Home page
Ann OncolHome page
G. Iconomou, A. Viha, A. Koutras, I. Koukourikou, V. Mega, T. Makatsoris, A. Onyenadum, K. Assimakopoulos, A. G. Vagenakis, and H. P. Kalofonos
Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial
Ann. Onc., March 1, 2006; 17(3): 515 - 520.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. T. Keating, K. Nayeem, J.J. Gilmartin, and S. T. O'Keeffe
Advance Directives for Truth Disclosure
Chest, August 1, 2005; 128(2): 1037 - 1039.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. R. Helft
Necessary Collusion: Prognostic Communication With Advanced Cancer Patients
J. Clin. Oncol., May 1, 2005; 23(13): 3146 - 3150.
[Full Text] [PDF]


Home page
JCOHome page
R. G. Hagerty, P. N. Butow, P. M. Ellis, E. A. Lobb, S. C. Pendlebury, N. Leighl, C. Mac Leod, and M. H.N. Tattersall
Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis
J. Clin. Oncol., February 20, 2005; 23(6): 1278 - 1288.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online